As the first-ever Medicare drug-price negotiations take shape, Big Pharma-backed Democrats want to limit the number of costly medicines regulators can target.
by Helen Santoro, The Lever
While President Joe Biden is using Medicare to lower the cost of a handful of overpriced drugs and wants to expand the practice to hundreds more, some of Big Pharma’s favorite Democrats are working to do the opposite.
After the pharmaceutical industry unleashed a $1.5 million bipartisan donation blitz, members of Biden’s own party have joined with Republican lawmakers to try to limit the number of drugs regulators can cut prices for in the future — an initiative Donald Trump is actively campaigning on in the lead-up to the 2024 presidential elections.
Democratic Reps. Scott Peters (Calif.), Wiley Nickel (N.C.), Josh Gottheimer (N.J.) and Donald Davis (N.C.) are each co-sponsoring at least one of several proposed bills that would limit regulators’ ability to negotiate down prices of drugs covered by the Medicare government insurance program. The legislation would erode the drug-pricing reforms included in the Democrats’ 2022 Inflation Reduction Act — efforts that Peters, Nickel, and Gottheimer supported. (Davis had not yet been elected to Congress.)
The four, who all hail from states with a major biotech or drug-industry presence, have together raked in more than $300,000 from pharmaceutical and health-products interests during the 2023-2024 congressional session. Gottheimer is reportedly eyeing a 2025 gubernatorial run in New Jersey, home to the pharmaceutical giant Merck & Co.
Recent Posts
New Poll Has An Independent Populist Upending The Senate With A Nebraska Upset
October 23, 2024
Take Action Now Dan Osborn is flipping the script, and a new poll has him flipping Nebraska’s crucial Senate seatBy Ryan Grim, Drop Site…
The Right Wants To Overturn A Foundational Labor Law
October 23, 2024
Take Action NowUnions need to plan a response now.By Shaun Richman, In These TimesThe foundational 1935 labor law…
The Democrats Have Always Been “Liberal” Interventionists
October 23, 2024
Take Action NowThe kind of progressivism that people expect from the Democratic Party has been subsumed by another politics.By…
Elon Musk’s Wants To Buy The U.S.’s Future
October 22, 2024
Take Action NowHere’s why Elon Musk’s million-dollar presidential lottery is ominous.By Sam Butler, Drop SiteElon Musk can…